AMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. META
4. NFLX
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. USO

Go back to AMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS

Morgan Stanley on Amgen (AMGN): 'We believe the acquisition will be viewed as a modest positive'

August 4, 2022 10:03 AM EDT

Morgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $253.00 price target on Amgen (NASDAQ: AMGN).

The analyst comments "We believe the acquisition will be viewed as a modest positive given investors are looking for mgt. to expand the pipeline and near-term revenues.... More